Skip to main content

Seelos Therapeutics, Inc.

SEELDelisted Apr 4, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001017491

Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Seelos Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of SEEL: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders8685−1
Shares31.3M27.2M−4.11M (−13.1%)
Value$21.3M$28.0M+$6.72M (+31.5%)

New holders (12)

Institutions that held Seelos Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to SEEL in Q3 2022
InstitutionSharesValue% of portfolio
HSBC Holdings PLC86,319$93.0K0.00%
WealthPlan Investment Management, LLC80,786$86.0K0.01%
SG Americas Securities, LLC54,092$56.0K0.00%
State of Wyoming28,942$30.0K0.01%
United Bank26,200$27.0K0.00%
Fortem Financial Group, LLC20,000$21.0K0.01%
Wolverine Trading, LLC13,097$14.0K0.00%
Kestra Advisory Services, LLC12,600$13.0K0.00%
Aptus Capital Advisors, LLC10,172$10.0K0.00%
Guardian Wealth Advisors, LLC10,154$10.0K0.00%
TD Waterhouse Canada Inc.2,000$2.08K0.00%
FinTrust Capital Advisors, LLC500$00.00%

Sold out (13)

Institutions that held Seelos Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of SEEL in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Penserra Capital Management LLC343,215$233.0K
HRT Financial LP87,694$59.0K
Jane Street Group, LLC24,951$17.0K
Balyasny Asset Management LLC18,729$13.0K
Y-Intercept (Hong Kong) Ltd16,233$11.0K
StoneX Group Inc.14,995$10.2K
Financial Counselors Inc10,000$7.00K
Legal & General Group Plc7,869$5.00K
New York State Common Retirement Fund824$1.00K
Citigroup Inc1,015$1.00K
Aquatic Capital Management LLC400$0
Curi Capital118$0
CoreCap Advisors, LLC100$0